Discovery and characterisation of a broderol‐like illudin, omphaderol in the mycelial extracts of Omphalotus mexicanus (Omphalotaceae) using UPLC‐QTOF‐MS and NMR spectroscopy

Abstract

AbstractIntroductionThe genus Omphalotus, in particular the “Jack‐O'Lantern mushrooms” Omphalotus illudens and Omphalotus olearius, are famous for the production of the DNA‐alkylating illudins. A lesser‐known species, Omphalotus mexicanus, native to Central America, also produces cytotoxic illudins S and M, but its minor secondary metabolites are yet to be investigated.ObjectiveTo identify, isolate, and elucidate the structure of novel secondary metabolites of the illudin family in mycelial extracts of O. mexicanus from submerse cultivation.MethodologyA fermentation of the fungus in 15 L stirred tank bioreactors is described. Mycelial extracts were separated using a combination of flash chromatography with preparative RP‐C18 high‐performance liquid chromatography (HPLC). Analysis of metabolites was done using an ultrahigh‐performance liquid chromatography ultraviolet diode array detector (UPLC‐UV‐DAD) system coupled to an electrospray ionisation quadrupole time‐of‐flight (ESI‐QTOF) mass spectrometer. Structures were elucidated using one‐dimensional (1D) and two‐dimensional (2D) nuclear magnetic resonance spectroscopy (NMR) techniques followed by comparison of experimental and simulated electronic circular dichroism (ECD) spectra to determine absolute configurations.ResultsTwo novel illudin derivatives, for which we propose the names omphaderol (1) and illudaneol B (2), as well as illudaneol (3) and the unusual cyclobutylcyclopentane illudosin (4), were isolated from the mycelia and characterised.ConclusionParticularly the illudaneol derivatives with their high titers may be potential building blocks for an alternative semisynthetic route to new illudin derivatives with improved medical properties. Additionally, the findings improve the knowledge of minor illudin compounds in the mycelial extract of this fungus and may be of significance for future biosynthetic studies of the illudins.